Luteolin downregulates IL-1β-induced MMP-9 and -13 expressions in osteoblasts via inhibition of ERK signalling pathway

References

• Krane SM. Clinical importance of metalloproteinases and their inhibitors. Ann N Y Acad Sci 1994;732:1–10.
   PubMed Web of Science ®Google Scholar
• Kusano K, Miyaura C, Inada M, Tamura T, Ito A, Nagase H et al. Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: Association of MMP induction with bone resorption. Endocrinology 1998;139:1338–1345.
   PubMed Web of Science ®Google Scholar
• Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491–21494.
   PubMed Web of Science ®Google Scholar
• Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: Involvement of three different collagenases. Arthritis Rheum 1997;40:2065–2074.
   PubMed Web of Science ®Google Scholar
• Teitelbaum SL. Bone resorption by osteoclasts. Science 2000;289:1504–1508.
   PubMed Web of Science ®Google Scholar
• Uchida M, Shima M, Shimoaka T, Fujieda A, Obara K, Suzuki H et al. Regulation of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol 2000;185:207–214.
   Google Scholar
• Ahmed S, Wang N, Lalonde M, Goldberg VM, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 2004;308:767–773.
   PubMed Web of Science ®Google Scholar
• Rodan GA, Martin TJ. Therapeutic approaches to bone diseases. Science 2000;289:1508–1514.
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Mix KS, Brinckerhoff CE. Matrix metalloproteinases as therapeutic targets in arthritic diseases: Bull’s-eye or missing the mark? Arthritis Rheum 2002;46:13–20.
   PubMed Web of Science ®Google Scholar
• Mix KS, Mengshol JA, Benbow U, Vincenti MP, Sporn MB, Brinckerhoff CE. A synthetic triterpenoid selectively inhibits the induction of matrix metalloproteinases 1 and 13 by inflammatory cytokines. Arthritis Rheum 2001;44:1096–1104.
   PubMed Web of Science ®Google Scholar
• Lee SO, Jeong YJ, Yu MH, Lee JW, Hwangbo MH, Kim CH, Lee IS. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-κB-dependent MMP-9 expression. Biochem Biophys Res Commun 2006;351:118–125.
   PubMed Web of Science ®Google Scholar
• Lim H, Kim HP. Inhibition of mammalian collagenase, matrix metalloproteinase-1, by naturally-occurring flavonoids. Planta Med 2007;73:1267–1274.
   PubMed Web of Science ®Google Scholar
• Lee MK, Choi H, Gil M, Nikodem VM. Regulation of osteoblast differentiation by Nurr1 in MC3T3-E1 cell line and mouse calvarial osteoblasts. J Cell Biochem 2006;99:986–994.
   Google Scholar
• Lee MK, Nikodem VM. Differential role of ERK in cAMP-induced Nurr1 expression in N2A and C6 cells. Neuroreport 2004;15:99–102.
   Google Scholar
• Amin R, Senga T, Oo ML, Thant AA, Hamaguchi M. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1β: A role for the dual signalling pathways, Akt and Erk. Gene cells 2003;8:515–523.
   Google Scholar
• Wu CY, Hsieh HL, Jou MJ, Yang CM. Involvement of p42/p44 MAPK, p38 MAPK, JNK and nuclear factor-κB in interleukin-1β-induced matrix metalloproteinase-9 expression in rat brain astrocytes. J Neurochem 2004;90:1477–1488.
   Google Scholar
• Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: Conserved structure and molecular mechanism. Nature 1991;349:117–127.
   PubMed Web of Science ®Google Scholar
• Campbell SL, Khosravi-Far R, Rossman KL, Clark GJ, Der CJ. Increasing complexity of Ras signaling. Oncogene 1998;17:1395–1413.
   PubMed Web of Science ®Google Scholar
• Wu J, Zern MA. Hepatic stellate cells: A target for the treatment of liver fibrosis. J Gastroenterol 2000;35:665–672.
   PubMed Web of Science ®Google Scholar
• Lin N, Sato T, Takayama Y, Mimaki Y, Sashida Y, Yano M et al. Novel anti-inflammatory actions of nobiletin, a citrus polymethoxy flavonoid, on human synovial fibroblasts and mouse macrophages. Biochem Pharmacol 2003;65:2065–2071.
   PubMed Web of Science ®Google Scholar
• de Bart AC, Quax PH, Löwik CW, Verheijen JH. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1α. J Bone Miner Res 1995;10:1374–1384.
   PubMedGoogle Scholar
• Chen CC, Chen JJ, Chou CY. Protein kinase c-α but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH(2)-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1β: Involvement of sequential activation of tyrosine kinase, nuclear factor-κB-inducing kinase, and IκB kinase 2. Mol Pharmacol 2000;58:1479–1489.
   Google Scholar
• Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor κB (NF-κB) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002;21:251–262.
   PubMed Web of Science ®Google Scholar
• Chen CC, Chow MP, Huang WC, Lin YC, Chang YJ. Flavonoids inhibit tumor necrosis factor-α-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-κB: Structure-activity relationships. Mol Pharmacol 2004;66:683–693.
   PubMed Web of Science ®Google Scholar
• Kim JS, Jobin C. The flavonoid luteolin prevents lipopolysaccharide-induced NF-κB signalling and gene expression by blocking IκB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology 2005;115:375–387.
   PubMed Web of Science ®Google Scholar